Zuari Agro Chemicals Limited has informed the Exchange regarding Board meeting held on May 14, 2025.
ZUARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zuari Agro Chemicals' board, at its May 14, 2025 meeting, approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025. On a consolidated basis, profit after tax (PAT) rose about 35% year-on-year to Rs 230.96 crore in FY25 from Rs 170.93 crore in FY24, while revenue declined roughly 10% to Rs 4,136 crore from Rs 4,595 crore. Standalone results swung to a Rs 73.10 crore loss in FY25 from a Rs 21.40 crore profit in FY24, hit by a temporary Mahad plant shutdown due to raw material shortages and lower other income. The statutory auditor (K.P. Rao & Co.) issued an unmodified opinion but drew attention to three emphasis-of-matter items: a SEBI show cause notice to the company and some key managerial personnel alleging past financial irregularities (for which a settlement application has been filed), a disputed Rs 29.14 crore urea subsidy recognition at subsidiary MCFL pending in the Delhi High Court, and the proposed merger of MCFL with Paradeep Phosphates Limited. The board also re-appointed Independent Director Sanjeev Lall for a second 3-year term and appointed new Cost, Internal, and Secretarial Auditors for FY26.
Consolidated earnings growth is a positive, supported by a strong contribution from the joint venture (PPL). However, standalone losses, declining top line, the Mahad plant shutdown, and ongoing regulatory and subsidy disputes create near-term uncertainty for shareholders.